Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Lilly image

Phoenix from the flames for Lilly cancer drug

August 14, 2013 Research and Development, Sales and Marketing NSCLC, lilly, lung cancer, necitumumab

A drug that once looked doomed to fail has shocked analysts by helping late-stage lung cancer patients live longer. Necitumumab …
News
anne_lindblad_emmes

New president and chief executive for EMMES

August 14, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMMES

Research support firm The EMMES Corporation has announced that its executive VP Dr Anne Lindblad has been promoted to president …
Appointment

The new NHS: a marriage of inconvenience?

August 13, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CCG, NHS England, andy lee, market access, quarry house

As NHS England tries to squeeze more money out of the healthcare budget to pay for specialist commissioning, Andy Lee …
Feature
Vical image

Vical melanoma drug dropped

August 13, 2013 Research and Development, Sales and Marketing Vical, allovectin, melanoma

Vical has abandoned trials of a late-stage drug for the deadliest form of skin cancer after the treatment failed to …
News
hugh

Hugh McCafferty joins Pharmafocus editorial team

August 12, 2013 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, pharmafile

Appointment

Funding boost for UK health research projects

August 12, 2013 Medical Communications, Research and Development, Sales and Marketing Lord Howe, NIHR, UK government, funding boost

News
Malaria image

Sanaria’s malaria vaccine shows promise

August 9, 2013 Research and Development, Sales and Marketing PfSPZ, Vaccine, malaria, sanaria

Researchers in the US have announced promising results from a Phase I clinical trial of biotech firm Sanaria’s new malaria …
News
NICE image

AllTrials campaign releases manifesto

August 9, 2013 Medical Communications, Research and Development, Sales and Marketing Bad pharma, GSK, Goldacre, NICE, transparency

The UK clinical trial transparency initiative AllTrials has released its first detailed manifesto as it looks to ramp up pressure …
News

GSK banks on bioelectronics with new fund

August 9, 2013 Medical Communications, Research and Development, Sales and Marketing Bioelectronics, COPD, GSK, asthma, diabetes

GSK has established a $50 million venture capital fund to invest in the emerging field of bioelectronics. Described as one …
News
glen_campbell_bmj

BMJ appoints US managing director

August 9, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMJ, Campbell

Medical journal BMJ has hired Glen Campbell from Elsevier to be its US managing director. Campbell joins BMJ on 2 …
Appointment
Afinitor image

Late-stage failure for Afinitor

August 8, 2013 Research and Development, Sales and Marketing Afinitor, Cancer, Novartis, liver

Novartis’ oncology programme has received a blow with the news that Afinitor has failed to help patients live longer in …
News
Eylea image

Eylea trial boost in DME

August 7, 2013 Research and Development, Sales and Marketing Bayer, DME, Eylea, regenenron

The rival treatment to Novartis’ Lucentis has posted encouraging new study results in patients with diabetic macular oedema (DME). In …
News
matt_foster

Waggener Edstrom expands UK healthcare team

August 7, 2013 Medical Communications, Research and Development, Sales and Marketing Waggener Edstrom, foster

Comms agency Waggener Edstrom Worldwide (WE) has appointed Matt Foster to its healthcare practice as an account director. Foster will …
Appointment

Bayer signs cancer vaccine research deal

August 6, 2013 Research and Development, Sales and Marketing Bayer, Vaccine, compugen

Bayer has entered into a new collaboration with Compugen to develop cancer vaccines aimed at helping the body fight off …
News
alan_copa

CRO Novum appoints vice president

August 6, 2013 Manufacturing and Production, Research and Development, Sales and Marketing alan copa, novum

Dr Alan Copa has joined contract research organisation Novum Pharmaceutical Research Services as vice president. “Dr. Copa brings a high …
Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026